|Application ||WB, IHC-P, E|
|Dilution||ELISA (1:100000-1:150000), IHC-P (10 µg/ml), WB (1:500)|
|Other Names||Plasminogen activator inhibitor 2, PAI-2, Monocyte Arg-serpin, Placental plasminogen activator inhibitor, Serpin B2, Urokinase inhibitor, SERPINB2, PAI2, PLANH2|
|Target/Specificity||Reactivity occurs against human PAI-2 protein. A BLAST analysis was used to suggest cross reactivity with PAI-2 proteins from several primates based on 94% homology with the immunizing sequence. Reactivity against homologues from other sources is not ...|
|Reconstitution & Storage||Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles.|
|Precautions||SERPINB2 / PAI-2 Antibody is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Inhibits urokinase-type plasminogen activator. The monocyte derived PAI-2 is distinct from the endothelial cell- derived PAI-1.|
|Cellular Location||Cytoplasm. Secreted, extracellular space.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Inhibits urokinase-type plasminogen activator. The monocyte derived PAI-2 is distinct from the endothelial cell- derived PAI-1.
Ye R.D.,et al.J. Biol. Chem. 262:3718-3725(1987).
Schleuning W.-D.,et al.Mol. Cell. Biol. 7:4564-4567(1987).
Webb A.C.,et al.J. Exp. Med. 166:77-94(1987).
Antalis T.M.,et al.Proc. Natl. Acad. Sci. U.S.A. 85:985-989(1988).
Ye R.D.,et al.J. Biol. Chem. 264:5495-5502(1989).
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.